Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 6/20 | 0.49 |
| ▸ | BACE1 | P56817 | 3/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.46 |
| ▸ | NPY1R | P25929 | 2/20 | 0.46 |
| ▸ | NPY4R | P50391 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3218913 | 1.00 | IL23R (0.49) | IL23RBACE1NPY5RNPY1RNPY4R | |
| SCHEMBL30558305 | 0.87 | NPY4R (0.51) | BACE1NPY5RNPY1RNPY4R | |
| SCHEMBL29815593 | 0.86 | KISS1R (0.52) | BACE1NPY5RNPY1RNPY4R | |
| SCHEMBL29883741 | 0.86 | IL23R (0.46) | IL23RNPY5RNPY1RNPY4R | |
| SCHEMBL31265328 | 0.86 | NPY4R (0.49) | NPY5RNPY1RNPY4R | |
| SCHEMBL30302999 | 0.86 | NPY4R (0.51) | NPY5RNPY1RNPY4R | |
| SCHEMBL30866942 | 0.85 | NPY4R (0.55) | BACE1NPY5RNPY1RNPY4R | |
| SCHEMBL30537833 | 0.84 | TFPI (0.61) | IL23RNPY5RNPY1RNPY4R | |
| SCHEMBL31410845 | 0.84 | TFPI (0.56) | IL23RNPY5RNPY1RNPY4R | |
| SCHEMBL29397501 | 0.83 | BACE1 (0.53) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962697-B2 | Bioreponsive polymers | INTERFACE BIOLOGICS INC. (CA) | 2015-02-24 | — | — | US | disclosed |
| US-20100041771-A1 | Bioreponsive Polymers | INTERFACE BIOLOGICS, INC. | 2010-02-18 | — | — | US | disclosed |
| EP-2040758-A2 | BIORESPONSIVE POLYMERS | Interface Biologics Inc. (CA) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008053362-A2 | BIORESPONSIVE POLYMERS | INTERFACE BIOLOGICS, INC. (CA) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041771-A1 | Bioreponsive Polymers | PEPD, PREP, DNPEP | IL23R 3742/4885BACE1 383/4885NPY5R 2786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.